Chronic disease management startup Phablecare has gained $25 million (Rs 187 crore) in its Series B funding round led by Kalaari Capital. Other participants in the round were Aflac Ventures, Stride Ventures and Digital Horizon. Existing investors Omron Ventures, SOSV, Fresco Capital and Social Starts also participated. 

Phablecare was founded by Sumit Sinha and Mukesh Bansal in 2017. The startup bridges the gap in chronic care management by offering remote consultations, insights and care. This helps the patient manage the chronic disease while staying out of the hospital. It also reduces costs for the patients. They deal in solving diabetes, hypertension, chronic kidney diseases, cardiovascular diseases and more. 

In March last year, the startup had raised Rs 90 crores led by Manipal Hospitals. They had raised another Rs 14 crore from Omron Ventures through primary capital infusion. Another Rs 45 crore was raised as venture debt from Stride Ventures. Last month, the startup acquired Fused Training, India’s first fitness platform for type 1 diabetes.

This funding round has marked a 6x evaluation of Phablecare. The funds will be used to accelerate market expansion, acquire talent and strengthen the ecosystem. They plan to capture 25% of the market within the next 2 years. Currently, the startup claims to have 1000 pharmacies, 10,000 doctors and over 3 million patients on board.